{"slideshow_credits": null, "snippet": "Valeant Pharmaceuticals disclosed that Goldman Sachs sold nearly 1.3 million shares in the drug maker, which were being held as collateral for a loan extended to Valeant\u2019s chief executive.", "abstract": "Valeant Pharmaceuticals chief executive J Michael Pearson has been forced by Goldman Sachs to sell almost 1.3 million of his shares in company to cover loan that bank gave him.", "section_name": "Business Day", "print_page": "6", "document_type": "article", "byline": {"person": [{"lastname": "de la MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. de la MERCED"}, "web_url": "http://www.nytimes.com/2015/11/07/business/dealbook/valeants-chief-forced-to-sell-company-shares-he-pledged-against-loans.html", "lead_paragraph": "Valeant Pharmaceuticals disclosed that Goldman Sachs sold nearly 1.3 million shares in the drug maker, which were being held as collateral for a loan extended to Valeant\u2019s chief executive.", "headline": {"main": "Valeant&#8217;s Chief Forced to Sell Company Shares He Pledged Against Loans", "print_headline": "Valeant&#8217;s Chief Forced to Sell Company Shares He Pledged Against Loans"}, "_id": "563d529938f0d82a02cd2a95", "word_count": "578", "multimedia": [{"height": 126, "url": "images/2015/10/27/business/27valeant/27valeant-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/10/27/business/27valeant/27valeant-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 395, "url": "images/2015/10/27/business/27valeant/27valeant-articleLarge.jpg", "legacy": {"xlarge": "images/2015/10/27/business/27valeant/27valeant-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "395"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/10/27/business/27valeant/27valeant-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/10/27/business/27valeant/27valeant-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-07T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Goldman Sachs Group Inc", "is_major": "Y", "rank": "2"}, {"name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}